Supira aims to compete with Johnson & Johnson’s Abiomed division and its family of miniaturized, catheter-based heart pumps, which the conglomerate acquired for $16.6 billion in late 2022.

Stereotaxis, a leader in surgical robotics, has announced the FDA submission for its first robotically navigated catheter, the EMAGIN™ 5F, aiming to expand Robotic Magnetic Navigation into ...